Related references
Note: Only part of the references are listed.Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease
Amanpreet Kaur et al.
CARDIOVASCULAR RESEARCH (2020)
Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study
Wael Sumaya et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Role of microRNAs in Venous Thromboembolism
Vania M. Morelli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Fourth universal definition of myocardial infarction (2018)
Kristian Thygesen et al.
EUROPEAN HEART JOURNAL (2019)
A revised systematic review and meta-analysis on the effect of statins on D-dimer levels
Suzanne Schol-Gelok et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2019)
Preanalytical Variables in Coagulation Testing: Setting the Stage for Accurate Results
Robert C. Gosselin et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Impaired endogenous fibrinolysis in ST-segment elevationmyocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study
Mohamed Farag et al.
EUROPEAN HEART JOURNAL (2019)
Plaque erosion: a new in vivo diagnosis and a potentialmajor shift in themanagement of patients with acute coronary syndromes
Ramon A. Partida et al.
EUROPEAN HEART JOURNAL (2018)
Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy
Wael Sumaya et al.
EUROPEAN HEART JOURNAL (2018)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Thrombomodulin can predict the incidence of second events in patients with acute coronary syndrome: Single-center, retrospective cohort study
Ryota Kosaki et al.
JOURNAL OF CARDIOLOGY (2018)
PLASMA CONCENTRATION OF BIOMARKERS REFLECTING ENDOTHELIAL CELL- AND GLYCOCALYX DAMAGE ARE INCREASED IN PATIENTS WITH SUSPECTED ST-ELEVATION MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK
Martin Frydland et al.
SHOCK (2018)
microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases?
Ana B. Arroyo et al.
THROMBOSIS RESEARCH (2018)
D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy)
Fahad AlKhalfan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated Heparin
Johanne Silvain et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2018)
Large-scale identification of functional microRNA targeting reveals cooperative regulation of the hemostatic system
J. Nourse et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome JACC State-of-the-Art Review
Guglielmo Gallone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
How is cardiac troponin released from injured myocardium?
Johannes Mair et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2018)
A review of commercially available thrombin generation assays
Jeremy Kintigh et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
Cardiac macrophages adopt profibrotic/M2 phenotype in infarcted hearts: Role of urokinase plasminogen activator
Signe Carlson et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease
Salim S. Hayek et al.
NATURE MEDICINE (2017)
Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study
Federica Tosi et al.
THROMBOSIS RESEARCH (2017)
How to use D-dimer in acute cardiovascular care
Evangelos Giannitsis et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2017)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi et al.
EUROPEAN HEART JOURNAL (2016)
Acquired intracoronary ADAMTS13 deficiency and VWF retention at sites of critical coronary stenosis in patients with STEMI
Giovanni Pedrazzini et al.
BLOOD (2016)
Kinetics of coagulation in ST-elevation myocardial infarction following successful primary percutaneous coronary intervention
Paul F. A. Teunissen et al.
THROMBOSIS RESEARCH (2016)
Residual thrombin potential predicts cardiovascular death in acute coronary syndrome patients undergoing percutaneous coronary intervention
Monica Attanasio et al.
THROMBOSIS RESEARCH (2016)
Updates on Acute Coronary Syndrome
Alon Eisen et al.
JAMA CARDIOLOGY (2016)
D-Dimer Levels Predict Myocardial Injury in ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study
Soonuk Choi et al.
PLOS ONE (2016)
Tissue Factor and Atherothrombosis
Kohei Tatsumi et al.
Journal of Atherosclerosis and Thrombosis (2015)
Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction
D. Leenaerts et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
MicroRNAs in hemostasis
R. Teruel-Montoya et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
C. H. Hansen et al.
THROMBOSIS JOURNAL (2015)
Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: A multicenter and multiethnic study
B. Rutten et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2015)
von Willebrand factor, Jedi knight of the bloodstream
Timothy A. Springer
BLOOD (2014)
Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis
Michelle A. H. Sonneveld et al.
BLOOD REVIEWS (2014)
Incidence, Predictors, and Implications of Reinfarction After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial
Samantha G. Stone et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2014)
Assessment of microRNAs in patients with unstable angina pectoris
Tanja Zeller et al.
EUROPEAN HEART JOURNAL (2014)
Circulating acute phase proteins in relation to extent and composition of coronary atherosclerosis and cardiovascular outcome: Results from the ATHEROREMO-IVUS study
Linda C. Battes et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy
Wouter J. Kikkert et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)
The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction
Ayhan Erkol et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)
Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events
Danny J. Eapen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Soluble Urokinase Plasminogen Activator Receptor for Risk Prediction in Patients Admitted with Acute Chest Pain
Stig Lyngbaek et al.
CLINICAL CHEMISTRY (2013)
Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study
Sara Ahmadi-Abhari et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2013)
Usefulness of Soluble Urokinase Plasminogen Activator Receptor to Predict Repeat Myocardial Infarction and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention
Stig Lyngbaek et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Fibrinolytic status hi acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways
Eduard Shantsila et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development
Roberto Gambari et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction
Shirley Uitte de Willige et al.
BLOOD (2011)
Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction
Tomas Jernberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Platelet-monocyte cross talk and tissue factor expression in stable angina vs. unstable angina/non ST-elevation myocardial infarction
Christoph W. Kopp et al.
PLATELETS (2011)
Is fibrin formation and thrombin generation increased during and after an acute coronary syndrome?
Mika Skeppholm et al.
THROMBOSIS RESEARCH (2011)
Altered Plasma Fibrin Clot Properties Are Associated With In-Stent Thrombosis
Anetta Undas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men
Mirjam E. Meltzer et al.
BLOOD (2010)
Coagulation Factors II, V, IX, X, XI, and XII, Plasminogen, and alpha-2 Antiplasmin and Risk of Coronary Heart Disease
Kazumasa Yamagishi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Impaired Endogenous Thrombolysis in Acute Coronary Syndrome Patients Predicts Cardiovascular Death and Nonfatal Myocardial Infarction
Smriti Saraf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Active platelet-binding conformation of plasma von Willebrand factor in young women with acute myocardial infarction
F. Peyvandi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Association of Thrombotic and Fibrinolytic Factors with Severity of Culprit Lesion in Patients with Acute Coronary Syndromes Without ST Elevation
Yasin Turker et al.
SOUTHERN MEDICAL JOURNAL (2010)
Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality
Aaron R. Folsom et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage
Nancy A. Turner et al.
BLOOD (2009)
Patients with acute coronary syndromes have low tissue factor activity and microparticle count, but normal concentration of tissue factor antigen in platelet free plasma - a pilot study
Martin Maly et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men
Mirjam E. Meltzer et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Tissue factor in patients with acute coronary syndromes - Expression in platelets, leukocytes, and platelet-leukocyte aggregates
Marta Brambilla et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes
Jessica L. Mega et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents
K. M. Katsaros et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
ADAMTS-13 activity in the presence of elevated von Willebrand factor levels as a novel mechanism of residual platelet reactivity in high risk coronary patients on antiplatelet treatment
Rossella Marcucci et al.
THROMBOSIS RESEARCH (2008)
Mechanisms of disease:: Platelet activation and atherothrombosis
Giovanni Davi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A multimarker risk stratification approach to non-ST elevation acute coronary syndrome:: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels
A. Tello-Montoliu et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Thrombin generation in plasma of healthy adults and children: Chromogenic versus fluorogenic thrombogram analysis
Katrien Devreese et al.
THROMBOSIS AND HAEMOSTASIS (2007)
Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention - The SEPIA-PCI trial
Marc Cohen et al.
CIRCULATION (2007)
Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM trial
Christina Christersson et al.
EUROPEAN HEART JOURNAL (2007)
Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease:: the AtheroGene study
P. E. Morange et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction
Trygve Brugger-Andersen et al.
THROMBOSIS RESEARCH (2007)
ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men
Chan K. N. K. Chion et al.
BLOOD (2007)
Anticoagulants in heart disease: current status and perspectives
Raffaele De Caterina et al.
EUROPEAN HEART JOURNAL (2007)
Curiouser and curiouser: Recent advances in measurement of thrombin-activatable fibirinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles
Michael B. Boffa et al.
CLINICAL BIOCHEMISTRY (2007)
Increasing post-event plasma thrombomodulin level associates with worse outcome in survival of acute coronary syndrome
Shih-Hung Chan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries:: Prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours
Mariann Gyoengyoesi et al.
THROMBOSIS AND HAEMOSTASIS (2006)
Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease
A Undas et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Biology and pharmacology of the platelet P2Y(12) receptor
Robert F. Storey
CURRENT PHARMACEUTICAL DESIGN (2006)
Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes
Roy F. M. van der Putten et al.
CLINICA CHIMICA ACTA (2006)
Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study
A Smith et al.
CIRCULATION (2005)
Endothelial cell markers and the risk of coronary heart disease - The Prospective Epidemiological Study of Myocardial Infarction (PRIME) study
PE Morange et al.
CIRCULATION (2004)
Antithrombin: in control of coagulation
NS Quinsey et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease
J Oldgren et al.
THROMBOSIS AND HAEMOSTASIS (2004)
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow
A Bernardo et al.
BLOOD (2004)
Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-ST-segment elevation myocardial infarction
M Gyongyosi et al.
AMERICAN HEART JOURNAL (2004)
Coagulation activation and long-term outcome in acute coronary syndromes
D Ardissino et al.
BLOOD (2003)
Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality
JP Collet et al.
CIRCULATION (2003)
Calibrated automated thrombin generation measurement in clotting plasma
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the North and South of Europe
I Juhan-Vague et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Statin prevents tissue factor expression in human endothelial cells -: Role of Rho/Rho-kinase and Akt pathways
M Eto et al.
CIRCULATION (2002)
Imbalance of plasminogen activator inhibitor-I/tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction
M Saigo et al.
THROMBOSIS AND HAEMOSTASIS (2001)
Plasminogen activator inhibitor type-1 (part one): Basic mechanisms, regulation, and role for thromboembolic disease
K Huber
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2001)
Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha 2-antiplasmin complex is an independent predictor of coronary re-events
M Redondo et al.
BLOOD COAGULATION & FIBRINOLYSIS (2001)
Activation of clotting factors XI and IX in patients with acute myocardial infarction
MC Minnema et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain
A Bayes-Genis et al.
AMERICAN HEART JOURNAL (2000)
Share Paper
